Evidence map›Paper›PMID 40568397›Full record

ArticleRwanda journal of medicine and health sciences2023

Outcomes of the Icare Rebound Tonometer versus the Gold Standard Tonometer in Measuring Intraocular Pressure among Mzuzu University Students, Malawi.

François Régis Twiringirimana, Clémentine Kanazayire, Okyere Bright Vandyke, Andrew Kanzunguze, Reverien Rutayisire, Grace Ogbona

Abstract read
In one paragraph

Article in Rwanda journal of medicine and health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

François Régis TwiringirimanaSchool of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Clémentine KanazayireSchool of Nursing and Midwifery, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Okyere Bright VandykeFaculty of Health Sciences, Mzuzu University, Mzuzu, Malawi.
Andrew KanzunguzeFaculty of Health Sciences, Mzuzu University, Mzuzu, Malawi.
Reverien RutayisireSchool of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Grace OgbonaFaculty of Health Sciences, Mzuzu University, Mzuzu, Malawi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The Goldmann Applanation Tonometer (GAT) is accepted as the gold standard tool to measure Intraocular Pressure (IOP). Besides, there is an emerging Icare Rebound Tonometer (RBT) which can be an alternative in terms of measuring IOP. Objective: This research aimed to analyze the agreement, and repeatability of intraocular pressure (IOP) measurements and compare the outcomes of RBT and GAT among Mzuzu University Students in Malawi. Methods: For this cross-sectional study, 107 participants aged 18 to 29 years underwent ophthalmic examination with three IOP measurements taken by two examiners using the RBT and the GAT. Results: The RBT and GAT were found to have a strong correlation (r=0.809, p>0.001), with an intra-class correlation of 0.787 (p>0.001). The mean difference of IOP measured by the two machines was 1.99±1.05mmHg, which was statistically significant. However, according to Bland-Altman analysis, there was no agreement between the results given by the two machines, with a bias of -1.979 (CI -2.28, -1.68, p > 0.001). In terms of repeatability, GAT was found to be better than RBT, with a CR of 7.512 and 10.418 respectively. Conclusion: The RBT and GAT can offer comparable IOP measures. Therefore, RBT can be recommended for community outreach programs where GAT cannot be employed.

Indexed as

Goldmann Applanation TonometerIcare Rebound TonometerIntraocular Pressure

Identifiers

PMID40568397
PMCPMC12110520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.